Showing results (131-140 of 245) with videos related to

Sort By:
Pageof 25
Blood Advances|July 16, 2025
Olutasidenib alone or combined with azacitidine in patients with mutant IDH1 myelodysplastic syndromeJorge E Cortes, Jay Yang, Gail J Roboz, et al.
Biomolecules|January 8, 2025
Rapid Detection of PML::RARA Fusions in Acute Promyelocytic Leukemia: CRISPR/Cas9 Nanopore Sequencing with Adaptive SamplingWilliam Middlezong, Victoria Stinnett, Michael Phan, et al.
Biology|June 24, 2022
Impact of FLT3-ITD Insertion Length on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort StudyElizabeth M Corley, Moaath K Mustafa Ali, Hanan Alharthy, et al.
Mycopathologia|March 17, 2005
Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristicsAasma Shaukat, Faris Bakri, Paul Young, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2013
Translational phase I trial of vorinostat (suberoylanilide hydroxamic acid) combined with cytarabine and etoposide in patients with relapsed, refractory, or high-risk acute myeloid leukemiaIvana Gojo, Ming Tan, Hong-Bin Fang, et al.
British Journal of Haematology|December 6, 2019
Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemiaNoa G Holtzman, Firas El Chaer, Maria R Baer, et al.
Annals of Hematology|October 10, 2025
Impact of clinical response and treatment tolerability on HRQoL in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinibAjibade Ashaye, Ling Shi, Ibrahim Aldoss, et al.
Cancer Medicine|April 1, 2025
Quality-Adjusted Time Without Symptoms of Disease or Toxicity (Q-TWiST) in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Comparison of Ponatinib Versus ImatinibAjibade Ashaye, Ling Shi, Ibrahim Aldoss, et al.
Frontiers in Oncology|April 4, 2022
Impact of IDH1 c.315C>T SNP on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort StudyElizabeth M Corley, Moaath K Mustafa Ali, Hanan Alharthy, et al.
Transplantation|December 16, 2004
Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletionTheresa Hahn, Arif Raza Alam, David Lawrence, et al.
Pageof 25